amiloride has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inkol, JM; Luu, AK; Mutsaers, AJ; Poon, AC | 1 |
| Fujita, T; Fukase, M; Kano, J; Sugimoto, T | 1 |
2 other study(ies) available for amiloride and Bone Cancer
| Article | Year |
|---|---|
Effects of the potassium-sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells.
Topics: Amiloride; Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Carboplatin; Cell Line, Tumor; Cell Proliferation; Dog Diseases; Dogs; Doxorubicin; Drug Therapy, Combination; Osteosarcoma; Proton Pump Inhibitors | 2019 |
Second messenger signaling in the regulation of cytosolic pH and DNA synthesis by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: role of Na+/H+ exchange.
Topics: Amiloride; Bone Neoplasms; Bucladesine; Calcimycin; Carrier Proteins; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Ionomycin; Osteoblasts; Osteosarcoma; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Peptide Fragments; Protein Kinase C; Proteins; Second Messenger Systems; Signal Transduction; Sodium-Hydrogen Exchangers; Teriparatide; Thymidine; Tritium; Tumor Cells, Cultured | 1992 |